Dr. Thatcher R. Heumann
Claim this profileVanderbilt University/Ingram Cancer Center
Studies Liver Cancer
Studies Cancer
7 reported clinical trials
18 drugs studied
Area of expertise
1Liver Cancer
Stage IV
Stage III
Stage I
2Cancer
Stage IV
Affiliated Hospitals
Clinical Trials Thatcher R. Heumann is currently running
Tinengotinib
for Bile Duct Cancer
This trial is testing an oral medication called Tinengotinib for patients with a specific type of bile duct cancer that has not responded to other treatments. The medication works by blocking a protein that helps cancer cells grow. The goal is to see if Tinengotinib can slow down or stop the cancer in these patients.
Recruiting2 awards Phase 3
ZEN003694 + Chemotherapy
for Colorectal Cancer
This phase I trial tests the safety, side effects, and best dose of ZEN003694 in combination with the usual treatment with capecitabine in treating patients with cancer that has spread from where it first started (primary site) to other places in the body (metastatic) or cannot be removed by surgery (unresectable) and that it has progressed on previous standard treatment. ZEN003694 is an inhibitor of a family of proteins called the bromodomain and extra-terminal (BET). It may prevent the growth of tumor cells that over produce BET protein. Capecitabine is in a class of medications called antimetabolites. It is taken up by cancer cells and breaks down into fluorouracil, a substance that kills cancer cells. Giving ZEN003694 in combination with capecitabine may be safe in treating patients with metastatic or unresectable solid tumors.
Recruiting1 award Phase 122 criteria
More about Thatcher R. Heumann
Clinical Trial Related4 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Thatcher R. Heumann has experience with
- Cisplatin
- Nivolumab
- Ipilimumab
- Tinengotinib
- Physician's Choice
- BAY 1895344
Breakdown of trials Thatcher R. Heumann has run
Liver Cancer
Cancer
Bile Duct Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Thatcher R. Heumann specialize in?
Thatcher R. Heumann focuses on Liver Cancer and Cancer. In particular, much of their work with Liver Cancer has involved Stage IV patients, or patients who are Stage III.
Is Thatcher R. Heumann currently recruiting for clinical trials?
Yes, Thatcher R. Heumann is currently recruiting for 2 clinical trials in Nashville Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Thatcher R. Heumann has studied deeply?
Yes, Thatcher R. Heumann has studied treatments such as Cisplatin, Nivolumab, Ipilimumab.
What is the best way to schedule an appointment with Thatcher R. Heumann?
Apply for one of the trials that Thatcher R. Heumann is conducting.
What is the office address of Thatcher R. Heumann?
The office of Thatcher R. Heumann is located at: Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee 37232 United States. This is the address for their practice at the Vanderbilt University/Ingram Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.